5967 related articles for article (PubMed ID: 2470106)
21. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.
Sharifi J; Khawli LA; Hu P; King S; Epstein AL
Hybrid Hybridomics; 2001; 20(5-6):305-12. PubMed ID: 11839248
[TBL] [Abstract][Full Text] [Related]
22. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
Harper JR; Bumol TF; Reisfeld RA
Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
Kantor RR; Ng AK; Giacomini P; Ferrone S
Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies.
Bystryn JC; Jacobsen JS; Liu P; Heaney-Kieras J
Hybridoma; 1982; 1(4):465-72. PubMed ID: 6208141
[TBL] [Abstract][Full Text] [Related]
25. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein.
Morgan AC; Galloway DR; Reisfeld RA
Hybridoma; 1981; 1(1):27-36. PubMed ID: 6208119
[TBL] [Abstract][Full Text] [Related]
26. Melanoma: the development of immunoconjugates from a preclinical viewpoint.
Beaumier PL; Morgan AC; Woodhouse CS; Marchitto KS
Immunol Ser; 1990; 53():297-316. PubMed ID: 2100562
[No Abstract] [Full Text] [Related]
27. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb.
Chen ZJ; Ferrone S
Ann N Y Acad Sci; 1993 Aug; 690():398-401. PubMed ID: 8368768
[No Abstract] [Full Text] [Related]
28. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP
Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135
[TBL] [Abstract][Full Text] [Related]
29. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
[TBL] [Abstract][Full Text] [Related]
30. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
Hellström I; Brown JP; Hellström KE
Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
[TBL] [Abstract][Full Text] [Related]
31. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
[No Abstract] [Full Text] [Related]
32. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
Chen ZJ; Yang H; Ferrone S
J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
[TBL] [Abstract][Full Text] [Related]
33. Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.
Oppezzo P; Osinaga E; Tello D; Bay S; Cantacuzene D; Irigoín F; Ferreira A; Roseto A; Cayota A; Alzari P; Pritsch O
Hybridoma; 2000 Jun; 19(3):229-39. PubMed ID: 10952411
[TBL] [Abstract][Full Text] [Related]
34. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
Riemer AB; Hantusch B; Sponer B; Kraml G; Hafner C; Zielinski CC; Scheiner O; Pehamberger H; Jensen-Jarolim E
Cancer Immunol Immunother; 2005 Jul; 54(7):677-84. PubMed ID: 15565329
[TBL] [Abstract][Full Text] [Related]
35. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
[TBL] [Abstract][Full Text] [Related]
36. Immunoreactivity affects the biodistribution and tumor targeting of radiolabeled anti-P97 Fab fragment.
Yokoyama K; Reynolds JC; Paik CH; Sood VK; Maloney PJ; Larson SM; Reba RC
J Nucl Med; 1990 Feb; 31(2):202-10. PubMed ID: 2313360
[TBL] [Abstract][Full Text] [Related]
37. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
Kan-Mitchell J; White WL; Mitchell MS
Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
[TBL] [Abstract][Full Text] [Related]
38. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
Kusama M; Kageshita T; Chen ZJ; Ferrone S
J Immunol; 1989 Dec; 143(11):3844-52. PubMed ID: 2584721
[TBL] [Abstract][Full Text] [Related]
39. Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA.
Matzku S; Kirchgessner H; Schmid U; Temponi M; Ferrone S
J Nucl Med; 1989 Mar; 30(3):390-7. PubMed ID: 2472474
[TBL] [Abstract][Full Text] [Related]
40. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
Wang X; Ko EC; Peng L; Gillies SD; Ferrone S
Cancer Res; 2005 Aug; 65(15):6976-83. PubMed ID: 16061683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
